Table 2.
Integrative review inclusion and exclusion criteria
| Inclusion | Exclusion |
|---|---|
| Papers exploring healthcare provider and/or patient families’ experiences of critical congenital heart disease^ diagnosis and/or management | Papers not including any element of healthcare provider and/or patient families’ experiences of critical congenital heart disease^ diagnosis and/or management |
| Paper describes majority of participants (= > 50%) with a diagnosis of critical congenital heart disease | Single case study or minority of participants with critical congenital heart disease |
| English language version available | No English language version available |
| Any children/fetuses with comorbidities (including genetic diagnoses and syndromes) | Infants with acquired cardiac disease |
| Empirical study | Review articles |
| Papers from Jan 1990 to July 2021 | Experiences of adult or adolescent patients with CCHD (> = 10 years of age) |
| Full text available | Papers prior to 1990 |
| Peer-reviewed studies | Full text unavailable |
| Dissertation studies not peer-reviewed |
^Heart defects classified as critical congenital heart disease include: aortic interruption or atresia or hypoplasia; coarctation or hypoplasia or the aortic arch; D-transposition of the great arteries; double-outlet right ventricle; Ebstein’s anomaly; hypoplastic left heart syndrome; single ventricle; pulmonary atresia intact septum; tetralogy of Fallot; total anomalous pulmonary venous connection; tricuspid stenosis and atresia, and truncus arteriosus